PortfoliosLab logoPortfoliosLab logo
PSCH vs. BBH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PSCH vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P SmallCap Health Care ETF (PSCH) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PSCH achieves a 1.80% return, which is significantly higher than BBH's -1.85% return. Over the past 10 years, PSCH has outperformed BBH with an annualized return of 6.81%, while BBH has yielded a comparatively lower 5.75% annualized return.


PSCH

1D
1.28%
1M
-0.71%
YTD
1.80%
6M
-1.68%
1Y
10.18%
3Y*
0.45%
5Y*
-5.72%
10Y*
6.81%

BBH

1D
2.22%
1M
0.09%
YTD
-1.85%
6M
-5.32%
1Y
23.92%
3Y*
6.14%
5Y*
0.31%
10Y*
5.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PSCH vs. BBH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PSCH
Invesco S&P SmallCap Health Care ETF
1.80%-0.49%3.77%-2.71%-25.15%5.75%31.47%20.17%9.15%34.87%
BBH
VanEck Vectors Biotech ETF
-1.85%21.18%-4.29%3.94%-15.25%11.81%22.13%26.34%-10.70%16.46%

Correlation

The correlation between PSCH and BBH is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.66

Correlation (3Y)
Calculated over the trailing 3-year period

0.68

Correlation (5Y)
Calculated over the trailing 5-year period

0.70

Correlation (10Y)
Calculated over the trailing 10-year period

0.68

Correlation (All Time)
Calculated using the full available price history since Apr 8, 2010

0.69

The correlation between PSCH and BBH has been stable across timeframes, ranging from 0.66 to 0.70 - a consistent structural relationship.

PSCH vs. BBH - Sectors Allocation Comparison


Sectors
PSCH
BBH

Healthcare

97.3%
99.9%

Technology

1.7%

-

Financial Services

1.1%

-

Industrials

0.7%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Real Estate

-

-

Utilities

-

-

Healthcare

PSCH
97.3%
BBH
99.9%

Technology

PSCH
1.7%
BBH

-

Financial Services

PSCH
1.1%
BBH

-

Industrials

PSCH
0.7%
BBH

-

Basic Materials

PSCH

-

BBH

-

Communication Services

PSCH

-

BBH

-

Consumer Cyclical

PSCH

-

BBH

-

Consumer Defensive

PSCH

-

BBH

-

Energy

PSCH

-

BBH

-

Real Estate

PSCH

-

BBH

-

Utilities

PSCH

-

BBH

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PSCH vs. BBH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSCH
PSCH Risk / Return Rank: 1717
Overall Rank
PSCH Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
PSCH Sortino Ratio Rank: 1717
Sortino Ratio Rank
PSCH Omega Ratio Rank: 1717
Omega Ratio Rank
PSCH Calmar Ratio Rank: 1717
Calmar Ratio Rank
PSCH Martin Ratio Rank: 1818
Martin Ratio Rank

BBH
BBH Risk / Return Rank: 3737
Overall Rank
BBH Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
BBH Sortino Ratio Rank: 3535
Sortino Ratio Rank
BBH Omega Ratio Rank: 3333
Omega Ratio Rank
BBH Calmar Ratio Rank: 4646
Calmar Ratio Rank
BBH Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSCH vs. BBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PSCHBBHDifference
Sharpe ratioReturn per unit of total volatility

-0.76

Sortino ratioReturn per unit of downside risk

-1.02

Omega ratioGain probability vs. loss probability

1.10

1.22

-0.12

Calmar ratioReturn relative to maximum drawdown

0.67

2.28

-1.61

Martin ratioReturn relative to average drawdown

1.84

5.81

-3.97

PSCH vs. BBH - Sharpe Ratio Comparison

The current PSCH Sharpe Ratio is 0.51, which is lower than the BBH Sharpe Ratio of 1.26. The chart below compares the historical Sharpe Ratios of PSCH and BBH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PSCHBBHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.51

1.26

-0.76

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.25

0.01

-0.27

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

0.26

+0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.51

0.38

+0.13

Drawdowns

PSCH vs. BBH - Drawdown Comparison

The maximum PSCH drawdown since its inception was -46.32%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for PSCH and BBH.


Loading charts...

Drawdown Indicators


PSCHBBHDifference

Max Drawdown

Largest peak-to-trough decline

-46.32%

-72.70%

+26.38%

Max Drawdown (1Y)

Largest decline over 1 year

-15.36%

-10.55%

-4.81%

Max Drawdown (3Y)

Largest decline over 3 years

-22.98%

-22.74%

-0.24%

Max Drawdown (5Y)

Largest decline over 5 years

-46.32%

-39.86%

-6.46%

Max Drawdown (10Y)

Largest decline over 10 years

-46.32%

-39.86%

-6.46%

Current Drawdown

Current decline from peak

-30.59%

-13.81%

-16.78%

Average Drawdown

Average peak-to-trough decline

-13.46%

-20.75%

+7.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.54%

4.13%

+1.41%

Volatility

PSCH vs. BBH - Volatility Comparison

The current volatility for Invesco S&P SmallCap Health Care ETF (PSCH) is 4.19%, while VanEck Vectors Biotech ETF (BBH) has a volatility of 6.06%. This indicates that PSCH experiences smaller price fluctuations and is considered to be less risky than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PSCHBBHDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.19%

6.06%

-1.87%

Volatility (6M)

Calculated over the trailing 6-month period

14.06%

14.28%

-0.22%

Volatility (1Y)

Calculated over the trailing 1-year period

20.26%

19.02%

+1.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.89%

21.50%

+1.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.63%

22.17%

+1.46%

PSCH vs. BBH - Expense Ratio Comparison

PSCH has a 0.29% expense ratio, which is lower than BBH's 0.35% expense ratio.


Dividends

PSCH vs. BBH - Dividend Comparison

PSCH's dividend yield for the trailing twelve months is around 0.01%, less than BBH's 0.51% yield.


PositionTTM20252024202320222021202020192018201720162015
BBH
VanEck Vectors Biotech ETF
0.51%0.51%0.80%0.43%0.47%0.21%0.36%0.34%0.50%0.55%0.30%0.27%
PSCH
Invesco S&P SmallCap Health Care ETF
0.01%0.04%0.27%0.01%2.27%0.00%0.00%0.00%0.00%0.00%0.03%0.00%

Frequently Asked Questions


PSCH and BBH have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBH has higher volatility (6.06%) compared to PSCH (4.19%). In terms of maximum drawdown, PSCH dropped -46.32% vs BBH's -72.70%.

On 10-year performance, PSCH leads with 6.81% vs 5.75% for BBH. On fees, PSCH is cheaper at 0.29% per year. On volatility, PSCH has been the lower-risk option at 4.19%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, PSCH has performed better with a 6.81% return vs 5.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

PSCH is cheaper with a 0.29% expense ratio, compared with 0.35% for BBH.

BBH has the higher dividend yield at 0.51%, compared with 0.01% for PSCH.

PSCH tracks S&P SmallCap 600 Health Care Index, while BBH tracks MVIS US Listed Biotech 25 Index. They also come from different issuers: Invesco and VanEck. Their fees differ too: 0.29% for PSCH and 0.35% for BBH.

BBH currently has the higher Sharpe Ratio (1.26 vs 0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PSCH and BBH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer